Cargando…

Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women

SUMMARY: A 36-month observational study compared the incidence of unaffected side hip fracture in Japanese female osteoporosis patients with a history of hip fracture between 173 patients receiving risedronate and 356 risedronate-untreated controls. New hip fractures were significantly less frequent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osaki, M., Tatsuki, K., Hashikawa, T., Norimatsu, T., Chiba, K., Motokawa, S., Furuichi, I., Doiguchi, Y., Aoyagi, K., Shindo, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261386/ https://www.ncbi.nlm.nih.gov/pubmed/21394496 http://dx.doi.org/10.1007/s00198-011-1556-7

Ejemplares similares

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Masud, Tahir, et al.
Publicado: (2009)

Risedronate’s Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis
por: Gates, Brian J., et al.
Publicado: (2012)

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study
por: Silverman, S. L., et al.
Publicado: (2006)

Effects of risedronate on fracture risk in postmenopausal women with osteopenia
por: Siris, E. S., et al.
Publicado: (2007)

Anti-fracture Efficacy of Monthly Risedronate Compared with That of Weekly Risedronate in Postmenopausal Korean Women with Osteoporosis: A Nationwide Cohort Study
por: Cho, Yong Ho, et al.
Publicado: (2020)

Higher incidence of aseptic loosening caused by a lower canal filling ratio with a modified modular stem in total hip arthroplasty
por: Kobayashi, Kyosuke, et al.
Publicado: (2020)

Osteoclast and Sclerostin Expression in Osteocytes in the Femoral Head with Risedronate Therapy in Patients with Hip Fractures: A Retrospective Comparative Study
por: Lee, Hwan-Hee, et al.
Publicado: (2022)

Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA
por: Eisman, John A., et al.
Publicado: (2023)

Effects of Risedronate on Osteoarthritis of the Knee
por: Iwamoto, Jun, et al.
Publicado: (2010)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study
por: Oliveira, Lindomar Guimarães, et al.
Publicado: (2015)

Associations of vertebral deformities and osteoarthritis with back pain among Japanese women: the Hizen-Oshima study
por: Kitahara, H., et al.
Publicado: (2012)

A 3-year postmarketing study on the safety and effectiveness of once-monthly risedronate in Japanese patients with osteoporosis
por: Soen, Satoshi, et al.
Publicado: (2020)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
por: Peralta, Ma. Florencia, et al.
Publicado: (2021)

Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate
por: Matsumoto, Y., et al.
Publicado: (2009)

Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance
por: Ke, Cheng‐hui, et al.
Publicado: (2021)

Risedronate inhibits human osteosarcoma cell invasion
por: Xin, Zeng Feng, et al.
Publicado: (2009)

Crystallization Products of Risedronate with Carbohydrates and Their Substituted Derivatives (†)
por: Kos, Jiri, et al.
Publicado: (2011)

Preparation of Risedronate Nanoparticles by Solvent Evaporation Technique
por: Vaculikova, Eliska, et al.
Publicado: (2014)

Effect of risedronate on bone loss at discontinuation of denosumab
por: Laroche, Michel, et al.
Publicado: (2020)

Risedronate-loaded aerogel scaffolds for bone regeneration
por: El-Wakil, Nahla, et al.
Publicado: (2022)

An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate
por: Kleinermans, Diane, et al.
Publicado: (2022)

Reducing hip fractures in the elderly
por: Leytin, Victoria, et al.
Publicado: (2011)

Efficacy of teriparatide compared with risedronate on FRAX(®)-defined major osteoporotic fractures: results of the VERO clinical trial
por: Body, J.-J., et al.
Publicado: (2020)

Effects of ergosteroside combined risedronate on fracture healing and BMP-2, BMP-7 and VEGF expression in rats
por: Xu, Xiaofeng, et al.
Publicado: (2021)

Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials
por: Mawatari, T., et al.
Publicado: (2016)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
por: Bobba, Raja, et al.
Publicado: (2007)

Effect of risedronate on femoral periprosthetic bone loss following total hip replacement: A systematic review and meta-analysis
por: Ren, Liang, et al.
Publicado: (2018)

Malnutrition, hypertension, and hyperlipidemia as risk factors for recurrent cellulitis
por: Norimatsu, Yurie, et al.
Publicado: (2021)

Association between number of medications and hip fractures in Japanese elderly using conditional logistic LASSO regression
por: Uematsu, Takuya, et al.
Publicado: (2023)

Hip fractures in the elderly without osteoporosis
por: Hadjimichael, Argyris Costa
Publicado: (2018)

Novel Anticoagulants and Hip Fractures in the Elderly
por: Matheron, George, et al.
Publicado: (2022)

Case of femoral diaphyseal stress fracture after long-term risedronate administration diagnosed by iliac bone biopsy
por: Nagai, Takashi, et al.
Publicado: (2013)

Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials
por: Shigematsu, Takashi, et al.
Publicado: (2017)

Lactobacillus paragasseri OLL2809 Improves Depression-Like Behavior and Increases Beneficial Gut Microbes in Mice
por: Hashikawa-Hobara, Narumi, et al.
Publicado: (2022)

Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial
por: Mawatari, Taro, et al.
Publicado: (2020)

Morbidity and Mortality following Surgery for Hip Fractures in Elderly Patients
por: Zaki, Hebattu-allah E., et al.
Publicado: (2019)

Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis
por: Li, Qifeng, et al.
Publicado: (2018)

Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
por: Asada, Yohei, et al.
Publicado: (2019)

Retraction: Preventive effects of risedronate and calcitriol on cancellous osteopenia in ratstreated with high-dose glucocorticoid
por: IWAMOTO, Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ggcbr59dcul7vjrgt8idncsdh0